US 11939361
Compositions of peptide inhibitors of Interleukin-23 receptor
granted A61KA61K38/00A61K38/10
Quick answer
US patent 11939361 (Compositions of peptide inhibitors of Interleukin-23 receptor) held by Protagonist Therapeutics, Inc. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61K38/10, A61K47/26, A61K47/38